Purine metabolism in heart failure: Oxidant biology and therapeutic indications

Congestive Heart Failure

Volumn 14, Issue 5, 2008, Pages 283-284

  Bauer, John Anthony ^a   Moffatt Bruce, Susan D ^b   Elton, Terry S ^c   Feldman, David ^d  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b Division of Cardiothoracic Surgery   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d Division of Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ENZYME INHIBITOR; PURINE; PURINE DERIVATIVE; URIC ACID; XANTHINE OXIDASE;

ARTICLE; DRUG ANTAGONISM; ENZYMOLOGY; HEART FAILURE; HUMAN; HYPERURICEMIA; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY;

ANTIOXIDANTS; ENZYME INHIBITORS; HEART FAILURE; HUMANS; HYPERURICEMIA; OXIDATIVE STRESS; PURINES; URIC ACID; XANTHINE OXIDASE;

EID: 58149392604     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2008.00011.x     Document Type: Note

References (6)

1. Kohn PM, Prozan GB. Hyperuricemia; relationship to hypercholesterolemia and acute myocardial infarction. JAMA. 1959;170:1909-1912.
2. Gertler MM, Garn SM, Levine SA. Serum uric acid in relation to age and physique in health and coronary heart disease. Ann Int Med. 1951;34:1421-1431.
3. Beard JT. Serum uric acid and coronary heart disease. Am Heart J. 1983;106:397-400.
4. Strasak AM, Kelleher CC, Brant L J, et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol. 2008;125(2):232-239.
5. George J, Carr E, Davies J, et al. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006;114(23):2508-2516.
6. Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131(1):7-13.